Citation: Zhilong Xie, Guohui Zhang, Ya Meng, Yefei Tong, Jian Deng, Honghui Li, Qingqing Ma, Shisong Han, Wenjun Ni. A natural nano-platform: Advances in drug delivery system with recombinant high-density lipoprotein[J]. Chinese Chemical Letters, ;2024, 35(11): 109584. doi: 10.1016/j.cclet.2024.109584 shu

A natural nano-platform: Advances in drug delivery system with recombinant high-density lipoprotein

Zhilong Xie ^{a, 1} ,
Guohui Zhang ^{b, 1} ,
Ya Meng ^b ,
Yefei Tong ^a ,
Jian Deng ^a ,
Honghui Li ^c ,
Qingqing Ma ^d ,
Shisong Han ^{b, *,} ,
Wenjun Ni ^{a, *,}

a.
Zhuhai Clinical Medical College of Jinan University (The Department of Urology, Zhuhai People's Hospital), Zhuhai 519050, China
b.
Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, Zhuhai People's Hospital (Zhuhai Clinical Medical College of Jinan University), Zhuhai 519050, China
c.
The Second Clinical Medical College, Guangdong Medical University, Dongguan 523808, China
d.
Guizhou Aerospace Hospital, Guizhou 563099, China

hanshs@qq.com

niwj5@jnu.edu.cn

Received Date: 2 December 2023
Revised Date: 19 January 2024
Accepted Date: 22 January 2024
Available Online: 30 January 2024

Figures(5)

Developing natural nano-platforms with high biocompatibility and natural targeting ability represents great significance for drug delivery. High-density lipoprotein (HDL), a natural lipid-protein complex, plays important roles in physiological activities, particularly in reverse cholesterol transport (RCT) and be closely associated with atherosclerotic cardiovascular diseases. Recent studies have demonstrated that HDLs have the potential to serve as ideal drug carriers. Recombinant HDLs (rHDLs) have been used to encapsulate substances such as small interfering RNA (siRNA), drugs, and contrast agents, fully utilizing the biocompatibility and targeting ability of rHDL in the body and providing new strategies for drug delivery and disease treatment. In this review, we discussed in detail the basic principles of HDL as a drug delivery system, the mechanisms of targeted drug delivery, and several methods for preparing HDL nanoparticles. Afterward, we comprehensively reviewed the applications of HDL as a drug carrier in cardiovascular diseases, cancer treatment (such as glioblastoma, breast cancer, hepatocellular carcinoma and urologic cancers) and some other fields. Finally, we reviewed the therapeutic effects and safety of HDL nanoparticles in clinical studies. Through a review and summary of these research advances, we aim to fully understand the potential of HDL as a drug carrier in clinical applications, providing valuable references and guidance for future research and expedites the translational application of HDL as drug carriers.
- High-density lipoproteins,
- Drug delivery,
- Apolipoprotein,
- Targeting mechanisms,
- HDL nanoparticle preparation,
- Cardiovascular disease,
- Cancer treatment
1. [1]
  M.F. Linton, P.G. Yancey, H. Tao, S.S. Davies, Circ. Res. 132 (2023) 1521– 1545. doi: 10.1161/CIRCRESAHA.123.321563
2. [2]
  P.W. Wilson, R.J. Garrison, W.P. Castelli, et al., Am. J. Cardiol. 46 (1980) 649–654. doi: 10.1016/0002-9149(80)90516-0
3. [3]
  S. Kumar, N. Maniya, C. Wang, S. Senapati, H.C. Chang, Nat. Commun. 14 (2023) 557. doi: 10.1038/s41467-023-36258-w
4. [4]
  P. Fotakis, V. Kothari, D.G. Thomas, et al., Arterioscler. Thromb. Vasc. Biol. 39 (2019) e253–e272.
5. [5]
  E.P.C. Van Der Vorst, K. Theodorou, Y. Wu, et al., Cell Metab. 25 (2017) 197–207. doi: 10.1016/j.cmet.2016.10.013
6. [6]
  A. Kontush, M.J. Chapman, Curr. Opin. Lipidol. 21 (2010) 312–318. doi: 10.1097/MOL.0b013e32833bcdc1
7. [7]
  A. Kontush, S. Chantepie, M.J. Chapman, Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1881–1888. doi: 10.1161/01.ATV.0000091338.93223.E8
8. [8]
  R. Kuai, D. Li, Y.E. Chen, J.J. Moon, A. Schwendeman, ACS Nano 10 (2016) 3015–3041. doi: 10.1021/acsnano.5b07522
9. [9]
  K. Thapa Magar, G.F. Boafo, X. Li, Z. Chen, W. He, Chin. Chem. Lett. 33 (2022) 587–596. doi: 10.1016/j.cclet.2021.08.020
10. [10]
  P. Zhu, Y. Liu, Y. Tang, et al., Chin. Chem. Lett. 35 (2024) 108689. doi: 10.1016/j.cclet.2023.108689
11. [11]
  Y. Zhou, D. Gao, Y. Wang, et al., Chin. Chem. Lett. 35 (2024) 108967. doi: 10.1016/j.cclet.2023.108967
12. [12]
  Q. Ouyang, Z. Duan, G. Jiao, J. Lei, Nanoscale Res. Lett. 10 (2015) 965.
13. [13]
  S. Sabnis, N.A. Sabnis, S. Raut, A.G. Lacko, Int. J. Nanomed. 12 (2017) 1453–1464. doi: 10.2147/IJN.S122036
14. [14]
  Q. Xiao, X. Li, Y. Li, et al., Acta Pharm. Sin. B 11 (2021) 941–960. doi: 10.1016/j.apsb.2020.12.018
15. [15]
  Y. Song, H. Jing, L.B. Vong, J. Wang, N. Li, Chin. Chem. Lett. 33 (2022) 1705–1717. doi: 10.1016/j.cclet.2021.10.055
16. [16]
  Y. Zhang, T. Sun, C. Jiang, Acta Pharm. Sin. B 8 (2018) 34–50. doi: 10.1016/j.apsb.2017.11.005
17. [17]
  Y. Matsuda, K. Hirata, N. Inoue, et al., Circ. Res. 72 (1993) 1103–1109. doi: 10.1161/01.RES.72.5.1103
18. [18]
  V. Gogonea, J. Peters, G.S. Gerstenecker, et al., Biomolecules 10 (2020) 121. doi: 10.3390/biom10010121
19. [19]
  S. Deng, Y. Xu, L. Zheng, Adv. Exp. Med. Biol. 1377 (2022) 1–11.
20. [20]
  R.S. Rosenson, H.B. Brewer, W.S. Davidson, et al., Circulation 125 (2012) 1905–1919. doi: 10.1161/CIRCULATIONAHA.111.066589
21. [21]
  S. Gatt, E.L. Bierman, J. Biol. Chem. 255 (1980) 3371–3376. doi: 10.1016/S0021-9258(19)85709-5
22. [22]
  X. Jiang, Z. Li, Adv. Exp. Med. Biol. 1372 (2022) 1–14.
23. [23]
  A. Kontush, M. Lindahl, M. Lhomme, et al., Handb. Exp. Pharmacol. 224 (2015) 3–51.
24. [24]
  C.G. Brouillette, G.M. Anantharamaiah, J.A. Engler, D.W. Borhani, Biochim. Biophys. Acta 1531 (2001) 4–46. doi: 10.1016/S1388-1981(01)00081-6
25. [25]
  B. Pan, J. Kong, J. Jin, et al., Biochim. Biophys. Acta 1861 (2016) 501–512. doi: 10.1016/j.bbalip.2016.03.022
26. [26]
  A.J. Mendez, G.M. Anantharamaiah, J.P. Segrest, J.F. Oram, J. Clin. Invest. 94 (1994) 1698–1705. doi: 10.1172/JCI117515
27. [27]
  S.C. Delk, A. Chattopadhyay, J.C. Escola-Gil, A.M. Fogelman, S.T. Reddy, Semin. Cancer Biol. 73 (2021) 158–168. doi: 10.1016/j.semcancer.2020.11.002
28. [28]
  H. Li, W. Liu, W. Su, et al., Infect. Genet. Evol. 91 (2021) 104804. doi: 10.1016/j.meegid.2021.104804
29. [29]
  J.D. Furtado, R. Yamamoto, J.T. Melchior, et al., Arterioscler. Thromb. Vasc. Biol. 38 (2018) 2827–2842. doi: 10.1161/ATVBAHA.118.311607
30. [30]
  H. Tang, Z. Xiang, L. Li, et al., Artif. Cells Nanomed. Biotechnol. 49 (2021) 565–575.
31. [31]
  S.A. Singh, A.B. Andraski, H. Higashi, et al., JCI Insight 6 (2021) e143526. doi: 10.1172/jci.insight.143526
32. [32]
  A. Zeljkovic, J. Vekic, S. Spasic, et al., Matern. Child Health J. 17 (2013) 556–565. doi: 10.1007/s10995-012-1031-x
33. [33]
  M. Stevanovic, J. Vekic, N. Bogavac-Stanojevic, et al., Biochem. Med. 28 (2018) 030713. doi: 10.11613/BM.2018.030713
34. [34]
  S.R.E. Khoudary, X. Chen, A. Nasr, et al., Arterioscler. Thromb. Vasc. Biol. 41 (2021) 951–961. doi: 10.1161/ATVBAHA.120.315355
35. [35]
  B. Zierfuss, C. Höbaus, C.T. Herz, et al., Thromb. Haemostasis 122 (2022) 1804–1813. doi: 10.1055/a-1827-7896
36. [36]
  Y. Yamauchi, S. Abe-Dohmae, S. Yokoyama, Biochim. Biophys. Acta 1585 (2002) 1–10. doi: 10.1016/S1388-1981(02)00304-9
37. [37]
  G.K. Hovingh, M.J.A. Van Wijland, A. Brownlie, et al., J. Lipid Res. 44 (2003) 1251–1255. doi: 10.1194/jlr.M300080-JLR200
38. [38]
  P.T. Duong, G.L. Weibel, S. Lund-Katz, G.H. Rothblat, M.C. Phillips, J. Lipid Res. 49 (2008) 1006–1014. doi: 10.1194/jlr.M700506-JLR200
39. [39]
  E.B. Neufeld, A.T. Remaley, S.J. Demosky, et al., J. Biol. Chem. 276 (2001) 27584–27590. doi: 10.1074/jbc.M103264200
40. [40]
  G. Schonfeld, B. Pfleger, R. Roy, J. Biol. Chem. 250 (1975) 7934–7950.
41. [41]
  J.F. Oram, Arterioscler. Thromb. Vasc. Biol. 23 (2003) 720–727. doi: 10.1161/01.ATV.0000054662.44688.9A
42. [42]
  S. Roosbeek, H. Caster, Q.Z. Liu, et al., Protein Expression Purif. 35 (2004) 102–110. doi: 10.1016/j.pep.2003.12.015
43. [43]
  J. Pei, Q. Cong, Protein Sci. 31 (2022) e4297. doi: 10.1002/pro.4297
44. [44]
  C.C. Schwartz, J.M. VandenBroek, P.S. Cooper, J. Lipid Res. 45 (2004) 1594–1607. doi: 10.1194/jlr.M300511-JLR200
45. [45]
  K.L. Ong, B.J. Cochran, B. Manandhar, S. Thomas, K.A. Rye, Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1867 (2022) 159119.
46. [46]
  A.J. Cupido, L.F. Reeskamp, A.D. Hingorani, et al., JAMA Cardiol 7 (2022) 955–964. doi: 10.1001/jamacardio.2022.2333
47. [47]
  S. Kajani, S. Curley, F.C. McGillicuddy, Int. J. Mol. Sci. 19 (2018) 1971. doi: 10.3390/ijms19071971
48. [48]
  J.A. Glomset, E.T. Janssen, R. Kennedy, J. Dobbins, J. Lipid Res. 7 (1966) 638–648.
49. [49]
  G.L. Burke, A.M. Arnold, D.E. Bild, et al., J. Am. Geriatr. Soc. 49 (2001) 254–262. doi: 10.1046/j.1532-5415.2001.4930254.x
50. [50]
  N. Santanam, S. Parthasarathy, Atherosclerosis 191 (2007) 272–275. doi: 10.1016/j.atherosclerosis.2006.05.027
51. [51]
  Q. Jin, E.S.H. Lau, A.O. Luk, et al., Cardiovasc. Diabetol. 21 (2022) 293. doi: 10.1186/s12933-022-01726-y
52. [52]
  S. Djekic, J. Vekic, A. Zeljkovic, et al., Int. J. Mol. Sci. 24 (2023) 9384. doi: 10.3390/ijms24119384
53. [53]
  D.J. Rader, G.K. Hovingh, Lancet 384 (2014) 618–625. doi: 10.1016/S0140-6736(14)61217-4
54. [54]
  M. Navab, S.T. Reddy, B.J. Van Lenten, A.M. Fogelman, Nat. Rev. Cardiol. 8 (2011) 222–232. doi: 10.1038/nrcardio.2010.222
55. [55]
  C. Grunfeld, M. Marshall, J.K. Shigenaga, et al., J. Lipid Res. 40 (1999) 245–252. doi: 10.1016/S0022-2275(20)33363-0
56. [56]
  Y. Luo, Y. Guo, H. Wang, et al., EBioMedicine 74 (2021) 103725. doi: 10.1016/j.ebiom.2021.103725
57. [57]
  M. Suzuki, D.K. Pritchard, L. Becker, et al., Circulation 122 (2010) 1919–1927. doi: 10.1161/CIRCULATIONAHA.110.961193
58. [58]
  L. Camont, M. Lhomme, F. Rached, et al., Arterioscler., Thromb., Vasc. Biol. 33 (2013) 2715–2723. doi: 10.1161/ATVBAHA.113.301468
59. [59]
  C. Jia, J.L.C. Anderson, E.G. Gruppen, et al., Circulation 143 (2021) 1935–1945. doi: 10.1161/CIRCULATIONAHA.120.050808
60. [60]
  A. Guzmán Rodríguez, M. Sablón Carrazana, C. Rodríguez Tanty, et al., Cancers 15 (2022) 4. doi: 10.3390/cancers15010004
61. [61]
  S. Wohlfart, A.S. Khalansky, S. Gelperina, D. Begley, J. Kreuter, J. Control. Release 154 (2011) 103–107. doi: 10.1016/j.jconrel.2011.05.010
62. [62]
  X. Zhou, Q. Ren, B. Wang, et al., J. Nanosci. Nanotechnol. 19 (2019) 5496–5502. doi: 10.1166/jnn.2019.16592
63. [63]
  I. Esobi, O. Olanrewaju, J. Echesabal-Chen, A. Stamatikos, Biomolecules 12 (2022) 679. doi: 10.3390/biom12050679
64. [64]
  M. Lee-Rueckert, J.C. Escola-Gil, P.T. Kovanen, Biochim. Biophys. Acta 1861 (2016) 566–583. doi: 10.1016/j.bbalip.2016.03.004
65. [65]
  S. Harashima, Y. Yamazaki, N. Motomura, et al., J. Steroid Biochem. Mol. Biol. 221 (2022) 106116. doi: 10.1016/j.jsbmb.2022.106116
66. [66]
  J. Liu, R. Voutilainen, P. Heikkilä, A.I. Kahri, J. Clin. Endocrinol. Metab. 82 (1997) 2522–2527.
67. [67]
  P.J. Pussinen, B. Karten, A. Wintersperger, et al., Biochem. J. 349 (2000) 559–566. doi: 10.1042/bj3490559
68. [68]
  T. Jiang, X. Diao, M. Ding, et al., J. Mol. Histol. 52 (2021) 539–544. doi: 10.1007/s10735-021-09963-3
69. [69]
  M. Pandey, G. Cuddihy, J.A. Gordon, M.E. Cox, K.M. Wasan, Pharmaceutics 13 (2021) 1509. doi: 10.3390/pharmaceutics13091509
70. [70]
  Y. Matsumura, H. Maeda, Cancer Res. 46 (1986) 6387–6392.
71. [71]
  F. Yuan, M. Dellian, D. Fukumura, et al., Cancer Res. 55 (1995) 3752–3756.
72. [72]
  R. Sun, J. Xiang, Q. Zhou, et al., Adv. Drug Deliv. Rev. 191 (2022) 114614. doi: 10.1016/j.addr.2022.114614
73. [73]
  G. Bort, F. Lux, S. Dufort, et al., Theranostics 10 (2020) 1319–1331. doi: 10.7150/thno.37543
74. [74]
  C.A. Fox, A. Moschetti, R.O. Ryan, Biochim. Biophys. Acta Mol. Cell Biol. Lipids 1866 (2021) 159025.
75. [75]
  S. Cai, Q. Yang, T.R. Bagby, M.L. Forrest, Adv. Drug Deliv. Rev. 63 (2011) 901–908. doi: 10.1016/j.addr.2011.05.017
76. [76]
  J. Fang, H. Nakamura, H. Maeda, Adv. Drug Deliv. Rev. 63 (2011) 136–151. doi: 10.1016/j.addr.2010.04.009
77. [77]
  Y. Shi, R. van der Meel, X. Chen, T. Lammers, Theranostics 10 (2020) 7921–7924. doi: 10.7150/thno.49577
78. [78]
  S. Vitols, S. Norgren, G. Juliusson, L. Tatidis, H. Luthman, Blood 84 (1994) 2689–2698. doi: 10.1182/blood.V84.8.2689.2689
79. [79]
  C.G. Leon, J.A. Locke, H.H. Adomat, et al., Prostate 70 (2010) 390–400. doi: 10.1002/pros.21072
80. [80]
  Y. Ding, Y. Wang, Y. Opoku-Damoah, et al., Biomaterials 72 (2015) 90–103. doi: 10.1016/j.biomaterials.2015.08.051
81. [81]
  R. Liu, C. Luo, Z. Pang, et al., Chin. Chem. Lett. 34 (2023) 107518. doi: 10.1016/j.cclet.2022.05.032
82. [82]
  X. Liu, X. Zhong, C. Li, Chin. Chem. Lett. 32 (2021) 2347–2358. doi: 10.1016/j.cclet.2021.03.015
83. [83]
  S. Qin, A. Zhang, S. Cheng, L. Rong, X. Zhang, Biomaterials 112 (2017) 234–247. doi: 10.1016/j.biomaterials.2016.10.016
84. [84]
  W. Yi, D. Yan, D. Wang, Y. Li, Cancer Biol. Med. 20 (2023) 248–267. doi: 10.20892/j.issn.2095-3941.2023.0009
85. [85]
  H. Zhang, S. Wang, M. Sun, et al., Front. Immunol. 13 (2022) 1093607.
86. [86]
  B. William, P. Noémie, E. Brigitte, P. Géraldine, Chem. Eng. J. 383 (2020) 123106. doi: 10.1016/j.cej.2019.123106
87. [87]
  A. Pluen, Y. Boucher, S. Ramanujan, et al., Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 4628–4633. doi: 10.1073/pnas.081626898
88. [88]
  V. Makwana, J. Karanjia, T. Haselhorst, S. Anoopkumar-Dukie, S. Rudrawar, Int. J. Pharm. 593 (2021) 120117. doi: 10.1016/j.ijpharm.2020.120117
89. [89]
  R. Kashapov, A. Ibragimova, R. Pavlov, et al., Int. J. Mol. Sci. 22 (2021) 7055. doi: 10.3390/ijms22137055
90. [90]
  P. Kumar, S. Agnihotri, I. Roy, Int. J. Nanomed. 13 (2018) 43–46. doi: 10.2147/IJN.S125002
91. [91]
  M.C. Didiot, L.M. Hall, A.H. Coles, et al., Mol. Ther. 24 (2016) 1836–1847. doi: 10.1038/mt.2016.126
92. [92]
  N. Parada, A. Romero-Trujillo, N. Georges, F. Alcayaga-Miranda, J. Adv. Res. 31 (2021) 61–74. doi: 10.1016/j.jare.2021.01.001
93. [93]
  J. Shao, J. Zaro, Y. Shen, Int. J. Nanomed. 15 (2020) 9355–9371. doi: 10.2147/IJN.S281890
94. [94]
  W. Jin, Z. Chen, Y. Wang, et al., Chin. Chem. Lett. 35 (2024) 109328. doi: 10.1016/j.cclet.2023.109328
95. [95]
  Z. Guo, W. Liu, T. Liu, et al., Chin. Chem. Lett. 35 (2024) 109060. doi: 10.1016/j.cclet.2023.109060
96. [96]
  Y. Zhang, C. Wischke, S. Mittal, A. Mitra, S.P. Schwendeman, Mol. Pharm. 13 (2016) 2622–2630. doi: 10.1021/acs.molpharmaceut.5b00961
97. [97]
  L. Bao, H. Huang, J. Zhao, K. Nakashima, Y. Gong, J. Biomater. Sci. Polym. Ed. 25 (2014) 1703–1716. doi: 10.1080/09205063.2014.952993
98. [98]
  D. Nie, Z. Dai, J. Li, et al., Nano Lett. 20 (2020) 936–946. doi: 10.1021/acs.nanolett.9b03817
99. [99]
  B.A. Kingwell, M.J. Chapman, Circulation 128 (2013) 1112–1121. doi: 10.1161/CIRCULATIONAHA.113.002683
100. [100]
  D.E. Nam, O.K. Kim, Y.K. Park, J. Lee, J. Med. Food 19 (2016) 62–67. doi: 10.1089/jmf.2015.3578
101. [101]
  L. Liu, H. He, M. Zhang, et al., Biomaterials 35 (2014) 8002–8014. doi: 10.1016/j.biomaterials.2014.05.081
102. [102]
  S. Marrache, S. Dhar, Proc. Natl. Acad. Sci. U. S. A. 110 (2013) 9445–9450. doi: 10.1073/pnas.1301929110
103. [103]
  R. Duivenvoorden, J. Tang, D.P. Cormode, et al., Nat. Commun. 5 (2014) 3065. doi: 10.1038/ncomms4065
104. [104]
  Y. Zhao, T. Imura, L.J. Leman, et al., J. Am. Chem. Soc. 135 (2013) 13414–13424. doi: 10.1021/ja404714a
105. [105]
  X. Li, J. Gu, Q. Xiao, et al., Chin. Chem. Lett. 34 (2023) 107483. doi: 10.1016/j.cclet.2022.04.081
106. [106]
  B. Romana, M. Batger, C.A. Prestidge, G. Colombo, F. Sonvico, Curr. Top. Med. Chem. 14 (2014) 1182–1193. doi: 10.2174/1568026614666140329232252
107. [107]
  B.L. Sanchez-Gaytan, F. Fay, M.E. Lobatto, et al., Bioconjugate Chem. 26 (2015) 443–451. doi: 10.1021/bc500517k
108. [108]
  G.Y. Lee, J.H. Kim, K.Y. Choi, et al., Biomaterials 53 (2015) 341–348. doi: 10.1016/j.biomaterials.2015.02.089
109. [109]
  M. Zhang, J. He, C. Jiang, et al., Int. J. Nanomed. 12 (2017) 533–558. doi: 10.2147/IJN.S124252
110. [110]
  B. Zheng, W.N. Yin, T. Suzuki, et al., Mol. Ther. 25 (2017) 1279–1294. doi: 10.1016/j.ymthe.2017.03.031
111. [111]
  J. Lu, Y. Zhao, X. Zhou, et al., Biomacromolecules 18 (2017) 2286–2295. doi: 10.1021/acs.biomac.7b00436
112. [112]
  T. Zhang, S. Zhou, L. Kang, et al., Asian J. Pharm. Sci. 12 (2017) 134–142. doi: 10.1016/j.ajps.2016.06.005
113. [113]
  K. Wang, C. Yu, Y. Liu, et al., ACS Biomater. Sci. Eng. 4 (2018) 952–962. doi: 10.1021/acsbiomaterials.7b00871
114. [114]
  T. Rong, B. Wei, M. Ao, et al., Int. J. Mol. Sci. 22 (2021) 13624. doi: 10.3390/ijms222413624
115. [115]
  Z. Shi, Q. Li, L. Mei, Chin. Chem. Lett. 31 (2020) 1345–1356. doi: 10.1016/j.cclet.2020.03.001
116. [116]
  J. Li, Z. Wang, H. Han, et al., Chin. Chem. Lett. 33 (2022) 1936–1940. doi: 10.1016/j.cclet.2021.10.058
117. [117]
  Y. Guo, W. Yuan, B. Yu, et al., EBioMedicine 28 (2018) 225–233. doi: 10.1016/j.ebiom.2017.12.021
118. [118]
  J.S. Rink, W. Sun, S. Misener, et al., ACS Appl. Mater. Interfaces 10 (2018) 6904–6916. doi: 10.1021/acsami.7b18525
119. [119]
  C. Xie, J. Liao, N. Zhang, et al., Chin. Chem. Lett. 35 (2024) 109149. doi: 10.1016/j.cclet.2023.109149
120. [120]
  Z. Balazs, U. Panzenboeck, A. Hammer, et al., J. Neurochem. 89 (2004) 939–950. doi: 10.1111/j.1471-4159.2004.02373.x
121. [121]
  J.L. Huang, G. Jiang, Q.X. Song, et al., Pharmazie 71 (2016) 709–714.
122. [122]
  J.H. Overmeyer, A. Kaul, E.E. Johnson, W.A. Maltese, Mol. Cancer Res. 6 (2008) 965–977. doi: 10.1158/1541-7786.MCR-07-2036
123. [123]
  J.L. Huang, G. Jiang, Q.X. Song, et al., Nat. Commun. 8 (2017) 15144. doi: 10.1038/ncomms15144
124. [124]
  L. Cui, Y. Wang, M. Liang, et al., Drug Deliv. 25 (2018) 1865–1876. doi: 10.1080/10717544.2018.1519002
125. [125]
  L. Scheetz, P. Kadiyala, X. Sun, et al., Clin. Cancer Res. 26 (2020) 4369–4380. doi: 10.1158/1078-0432.CCR-20-0341
126. [126]
  Q. Song, H. Song, J. Xu, et al., Mol. Pharm. 13 (2016) 3976–3987. doi: 10.1021/acs.molpharmaceut.6b00781
127. [127]
  S. Fernández-de-Retana, M. Cano-Sarabia, P. Marazuela, et al., Sci. Rep. 7 (2017) 14637. doi: 10.1038/s41598-017-15215-w
128. [128]
  L. Lu, S. Qi, Y. Chen, et al., Biomaterials 245 (2020) 119987. doi: 10.1016/j.biomaterials.2020.119987
129. [129]
  M.L. Schultz, M.V. Fawaz, R.D. Azaria, et al., BMC Med. 17 (2019) 200. doi: 10.1186/s12916-019-1423-5
130. [130]
  C. Danilo, J.L. Gutierrez-Pajares, M.A. Mainieri, et al., Breast Cancer Res 15 (2013) R87. doi: 10.1186/bcr3483
131. [131]
  Y. Ding, Y. Wang, J. Zhou, et al., Biomaterials 35 (2014) 7214–7227. doi: 10.1016/j.biomaterials.2014.05.009
132. [132]
  W. Alshaer, H. Zureigat, A.A. Karaki, et al., Eur. J. Pharmacol. 905 (2021) 174178. doi: 10.1016/j.ejphar.2021.174178
133. [133]
  M.J.W. Evers, S.I. van de Wakker, E.M. de Groot, et al., Adv. Healthc. Mater. 11 (2022) e2101202. doi: 10.1002/adhm.202101202
134. [134]
  L. Zhang, Z. Dong, S. Yu, et al., Chin. Chem. Lett. 35 (2024) 109101. doi: 10.1016/j.cclet.2023.109101
135. [135]
  L. Zhao, C. Gu, Y. Gan, et al., J. Control. Release 318 (2020) 1–15. doi: 10.1016/j.jconrel.2019.12.005
136. [136]
  S. Guo, B. Liu, M. Zhang, et al., Chin. Chem. Lett. 32 (2021) 102–106. doi: 10.1016/j.cclet.2020.11.024
137. [137]
  F. Zhang, X. Wang, X. Xu, et al., Eur. J. Pharm. Sci. 92 (2016) 11–21. doi: 10.1016/j.ejps.2016.06.017
138. [138]
  C. Mani, K. Tripathi, T.R. Omy, et al., Biochim. Biophys. Acta Mol. Basis Dis. 1868 (2022) 166300. doi: 10.1016/j.bbadis.2021.166300
139. [139]
  H. Wang, X. Wang, Y. Zhang, et al., Biomacromolecules 21 (2020) 5119–5127. doi: 10.1021/acs.biomac.0c01253
140. [140]
  C. Jiang, X. Wang, B. Teng, et al., ACS Appl. Mater. Interfaces 13 (2021) 35248–35265. doi: 10.1021/acsami.1c02074
141. [141]
  T. Wang, C. Subramanian, M. Yu, et al., Surgery 166 (2019) 1168–1175. doi: 10.1016/j.surg.2019.06.010
142. [142]
  H. Wang, Y. Tsai, Y. Wu, et al., PLoS ONE 7 (2012) e37764. doi: 10.1371/journal.pone.0037764
143. [143]
  M. Rui, H. Tang, Y. Li, X. Wei, Y. Xu, Pharm. Res. 30 (2013) 1203–1214. doi: 10.1007/s11095-012-0957-4
144. [144]
  J. Xie, Y. Lu, B. Yu, J. Wu, J. Liu, Chin. Chem. Lett. 31 (2020) 1173–1177. doi: 10.1016/j.cclet.2019.10.030
145. [145]
  F. Kong, Q. Ye, X. Miao, et al., Theranostics 11 (2021) 5464–5490. doi: 10.7150/thno.54822
146. [146]
  Q. Guo, C. Li, W. Zhou, et al., Acta Pharm. Sin. B 9 (2019) 832–842. doi: 10.1016/j.apsb.2019.01.012
147. [147]
  M. Li, Y. Su, F. Zhang, et al., Acta Biomater 75 (2018) 413–426. doi: 10.1016/j.actbio.2018.05.049
148. [148]
  Q. Li, J. Fan, H. Mu, et al., Chin. Chem. Lett. 35 (2024) 108947. doi: 10.1016/j.cclet.2023.108947
149. [149]
  H. Moch, M.B. Amin, D.M. Berney, et al., Eur. Urol. 82 (2022) 458–468. doi: 10.1016/j.eururo.2022.06.016
150. [150]
  G.J. Netto, M.B. Amin, D.M. Berney, et al., Eur. Urol. 82 (2022) 469–482. doi: 10.1016/j.eururo.2022.07.002
151. [151]
  A.N. Araújo, M.J. Bugalho, Horm. Metab. Res. 53 (2021) 285–292. doi: 10.1055/a-1453-0806
152. [152]
  M. Fassnacht, M. Terzolo, B. Allolio, et al., N. Engl. J. Med. 366 (2012) 2189–2197. doi: 10.1056/NEJMoa1200966
153. [153]
  C. Subramanian, R. Kuai, Q. Zhu, et al., Surgery 159 (2016) 284–294. doi: 10.1016/j.surg.2015.08.023
154. [154]
  R. Kuai, C. Subramanian, P.T. White, et al., Int. J. Nanomed. 12 (2017) 6581–6594. doi: 10.2147/IJN.S140591
155. [155]
  L. Yang, J. Sun, M. Li, et al., Cancer Res. 81 (2021) 5720–5732. doi: 10.1158/0008-5472.CAN-21-0646
156. [156]
  M. Obaidul Islam, T. Bacchetti, H. Berrougui, A. Khalil, G. Ferretti, Exp. Mol. Pathol. 126 (2022) 104777. doi: 10.1016/j.yexmp.2022.104777
157. [157]
  O.A. Andreassen, V. Zuber, W.K. Thompson, et al., Int. J. Epidemiol. 43 (2014) 1205–1214. doi: 10.1093/ije/dyu090
158. [158]
  C.J. Bull, C. Bonilla, J.M.P. Holly, et al., Cancer Med. 5 (2016) 1125–1136. doi: 10.1002/cam4.695
159. [159]
  G. Revilla, L. Cedó, M. Tondo, et al., Semin. Cancer Biol. 73 (2021) 134–157. doi: 10.1016/j.semcancer.2020.11.012
160. [160]
  J.A. Gordon, J.W. Noble, A. Midha, et al., Cancer Res. 79 (2019) 3320–3331.
161. [161]
  K.M. McMahon, M.P. Plebanek, C.S. Thaxton, Adv. Funct. Mater. 26 (2016) 7824–7835. doi: 10.1002/adfm.201602600
162. [162]
  R.N. Alolga, Y. Opoku-Damoah, D.A. Alagpulinsa, et al., Biomaterials 268 (2021) 120482. doi: 10.1016/j.biomaterials.2020.120482
163. [163]
  X. Liu, R. Guo, S. Huo, et al., J. Control. Release 343 (2022) 314–325. doi: 10.1016/j.jconrel.2022.01.029
164. [164]
  L. Mei, M. Yu, Y. Liu, et al., Nanomedicine 44 (2022) 102571. doi: 10.1016/j.nano.2022.102571
1. [1]
  Tong Tong , Lezong Chen , Siying Wu , Zhong Cao , Yuanbin Song , Jun Wu . Establishment of a leucine-based poly(ester amide)s library with self-anticancer effect as nano-drug carrier for colorectal cancer treatment. Chinese Chemical Letters, 2024, 35(12): 109689-. doi: 10.1016/j.cclet.2024.109689
2. [2]
  Jiaqi Huang , Renjiang Kong , Yanmei Li , Ni Yan , Yeyang Wu , Ziwen Qiu , Zhenming Lu , Xiaona Rao , Shiying Li , Hong Cheng . Feedback enhanced tumor targeting delivery of albumin-based nanomedicine to amplify photodynamic therapy by regulating AMPK signaling and inhibiting GSTs. Chinese Chemical Letters, 2024, 35(8): 109254-. doi: 10.1016/j.cclet.2023.109254
3. [3]
  Linghui Zou , Meng Cheng , Kaili Hu , Jianfang Feng , Liangxing Tu . Vesicular drug delivery systems for oral absorption enhancement. Chinese Chemical Letters, 2024, 35(7): 109129-. doi: 10.1016/j.cclet.2023.109129
4. [4]
  Yinglan Yu , Sajid Hussain , Jianping Qi , Lei Luo , Xuemei Zhang . Mechanisms and applications: Cargos transport to basolateral membranes in polarized epithelial cells. Chinese Chemical Letters, 2024, 35(12): 109673-. doi: 10.1016/j.cclet.2024.109673
5. [5]
  Yuanzheng Wang , Chen Zhang , Shuyan Han , Xiaoli Kong , Changyun Quan , Jun Wu , Wei Zhang . Cancer cell membrane camouflaged biomimetic gelatin-based nanogel for tumor inhibition. Chinese Chemical Letters, 2024, 35(11): 109578-. doi: 10.1016/j.cclet.2024.109578
6. [6]
  Makhloufi Zoulikha , Zhongjian Chen , Jun Wu , Wei He . Approved delivery strategies for biopharmaceuticals. Chinese Chemical Letters, 2025, 36(2): 110225-. doi: 10.1016/j.cclet.2024.110225
7. [7]
  Jing Zhang , Charles Wang , Yaoyao Zhang , Haining Xia , Yujuan Wang , Kun Ma , Junfeng Wang . Application of magnetotactic bacteria as engineering microrobots: Higher delivery efficiency of antitumor medicine. Chinese Chemical Letters, 2024, 35(10): 109420-. doi: 10.1016/j.cclet.2023.109420
8. [8]
  Yujie Li , Ya-Nan Wang , Yin-Gen Luo , Hongcai Yang , Jinrui Ren , Xiao Li . Advances in synthetic biology-based drug delivery systems for disease treatment. Chinese Chemical Letters, 2024, 35(11): 109576-. doi: 10.1016/j.cclet.2024.109576
9. [9]
  Lihang Wang , Mary Li Javier , Chunshan Luo , Tingsheng Lu , Shudan Yao , Bing Qiu , Yun Wang , Yunfeng Lin . Research advances of tetrahedral framework nucleic acid-based systems in biomedicine. Chinese Chemical Letters, 2024, 35(11): 109591-. doi: 10.1016/j.cclet.2024.109591
10. [10]
  Yong-Dan Zhao , Yidan Wang , Rongrong Wang , Lina Chen , Hengtong Zuo , Xi Wang , Jihong Qiang , Geng Wang , Qingxia Li , Canqi Ping , Shuqiu Zhang , Hao Wang . Reversing artemisinin resistance by leveraging thermo-responsive nanoplatform to downregulating GSH. Chinese Chemical Letters, 2024, 35(6): 108929-. doi: 10.1016/j.cclet.2023.108929
11. [11]
  Keyang Li , Yanan Wang , Yatao Xu , Guohua Shi , Sixian Wei , Xue Zhang , Baomei Zhang , Qiang Jia , Huanhua Xu , Liangmin Yu , Jun Wu , Zhiyu He . Flash nanocomplexation (FNC): A new microvolume mixing method for nanomedicine formulation. Chinese Chemical Letters, 2024, 35(10): 109511-. doi: 10.1016/j.cclet.2024.109511
12. [12]
  Qiang Li , Jiangbo Fan , Hongkai Mu , Lin Chen , Yongzhen Yang , Shiping Yu . Nucleus-targeting orange-emissive carbon dots delivery adriamycin for enhanced anti-liver cancer therapy. Chinese Chemical Letters, 2024, 35(6): 108947-. doi: 10.1016/j.cclet.2023.108947
13. [13]
  Zian Lin , Yingxue Jin . Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry (MALDI-MS) for Disease Marker Screening and Identification: A Comprehensive Experiment Teaching Reform in Instrumental Analysis. University Chemistry, 2024, 39(11): 327-334. doi: 10.12461/PKU.DXHX202403066
14. [14]
  Fengjie Liu , Fansu Meng , Zhenjiang Yang , Huan Wang , Yuehong Ren , Yu Cai , Xingwang Zhang . Exosome-biomimetic nanocarriers for oral drug delivery. Chinese Chemical Letters, 2024, 35(9): 109335-. doi: 10.1016/j.cclet.2023.109335
15. [15]
  Shaoqing Du , Xinyong Liu , Xueping Hu , Peng Zhan . Targeting novel sites represents an effective strategy for combating drug resistance. Chinese Chemical Letters, 2025, 36(1): 110378-. doi: 10.1016/j.cclet.2024.110378
16. [16]
  Wenlong Li , Feishi Shan , Qingdong Bao , Qinghua Li , Hua Gao , Leyong Wang . Supramolecular assembly nanoparticle for trans-epithelial treatment of keratoconus. Chinese Chemical Letters, 2024, 35(10): 110060-. doi: 10.1016/j.cclet.2024.110060
17. [17]
  Zhe-Han Yang , Jie Yin , Lei Xin , Yuanfang Li , Yijie Huang , Ruo Yuan , Ying Zhuo . Research advancement of DNA-based intelligent hydrogels: Manufacture, characteristics, application of disease diagnosis and treatment. Chinese Chemical Letters, 2024, 35(10): 109558-. doi: 10.1016/j.cclet.2024.109558
18. [18]
  Cheng-Zhe Gao , Hao-Ran Jia , Tian-Yu Wang , Xiao-Yu Zhu , Xiaofeng Han , Fu-Gen Wu . A dual drug-loaded tumor vasculature-targeting liposome for tumor vasculature disruption and hypoxia-enhanced chemotherapy. Chinese Chemical Letters, 2025, 36(1): 109840-. doi: 10.1016/j.cclet.2024.109840
19. [19]
  Haijing Cui , Weihao Zhu , Chuning Yue , Ming Yang , Wenzhi Ren , Aiguo Wu . Recent progress of ultrasound-responsive titanium dioxide sonosensitizers in cancer treatment. Chinese Chemical Letters, 2024, 35(10): 109727-. doi: 10.1016/j.cclet.2024.109727
20. [20]
  Yulong Liu , Haoran Lu , Tong Yang , Peng Cheng , Xu Han , Wenyan Liang . Catalytic applications of amorphous alloys in wastewater treatment: A review on mechanisms, recent trends, challenges and future directions. Chinese Chemical Letters, 2024, 35(10): 109492-. doi: 10.1016/j.cclet.2024.109492

Get Citation

PDF

XML

Metrics

PDF Downloads(1)
Abstract views(180)
HTML views(8)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142